Business Wire

CB Insights Announces Collaboration with Snowflake to Make Market Intelligence Accessible to AI and Agents in Real Time

Share

Joint customers can now deploy CB Insights directly within their Snowflake environment

CB Insights, the leading provider of predictive market intelligence, today announced at Snowflake’s annual user conference, Snowflake Summit 2025, a collaboration with Snowflake, the AI Data Cloud company. Through this collaboration, CB Insights’ continuously validated data on more than 10 million companies, 1,500 tech markets, and how they all compare is now available via the Snowflake Marketplace. Joint customers can now simply “point and click” to use the data in their AI, agents, dashboards, and other enterprise applications.

“To build agents and AI that are effective, enterprises need more than internal data—they need reliable, structured context about what’s happening in the world outside their four walls,” said Manlio Carrelli, CEO of CB Insights. “We provide that external intelligence layer: on the markets you’re in, the competitors you’re up against, the companies you should buy, partner with, or learn from. Our collaboration with Snowflake makes embedding that context in your AI, dashboards and enterprise apps as simple as a few clicks.”

“The best AI outcomes come from the best data,” said Kieran Kennedy, VP, Data Cloud Product Partners, Snowflake. “CB Insights delivers high-quality, context-rich data that helps our joint customers act faster and smarter. We’re excited to welcome them to the Snowflake Marketplace—and to use their terminal ourselves to improve our own decision-making.”

By combining CB Insights’ proprietary external intelligence with Snowflake’s secure, data and AI platform, the two companies enable powerful use cases:

  • Improved LLM accuracy by training on validated data about companies and technologies

  • Increased the effectiveness of AI agents by giving them “world context” about what’s happening outside your company’s four walls in the companies and markets you care about

  • Enriched dashboards and workflows for business functions. For example, a business development dashboard can include insight into competitor business relationships or AI-generated SWOT analyses on prospective partners.

Unlike traditional market intelligence databases, CB Insights’ dataset is built through a proprietary “double validation” pipeline that uses machine learning to continuously analyze and confirm data on management teams, fundings, partnerships, deals, earnings calls, investor activity, hiring patterns, patents and more—transforming global business activity into structured, decision-ready signals.

The CB Insights-Snowflake integration allows joint customers to simply “point” to CB Insights data and make it instantly and securely available to their internal applications built on Cortex AI —without having to move the data. This allows enterprises to avoid manual ETL (Extract, Transform, Load) pipelines and API complexity. Key benefits:

  • Ready for AI and BI: Use CB Insights data in agents, LLMs, dashboards, and planning tools.

  • Trusted, Validated Signals: Make better decisions with continuously verified insights into markets, competitors, and technologies.

  • Faster Time-to-Value: Eliminate ETL and adoption friction—activate the data in minutes via Snowflake Marketplace.

To learn more about the CB Insights-Snowflake collaboration, visit www.cbinsights.com/snowflake/.

About CB Insights

Headquartered in New York City, CB Insights is the leading provider of AI for market intelligence. The company aggregates, validates, and analyzes hard-to-find private and public company data. Its powerful AI tells users what it all means to them personally. The world’s smartest companies rely on CB Insights to focus on the right markets, stay ahead of competitors, and identify the right targets for sales, partnership, or acquisition. Visit www.cbinsights.com for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250603304794/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline4.9.2025 07:00:00 CEST | Press release

Funding to support Phase 2b trial with MRM Health’s lead program MH002 in ulcerative colitis and advance two additional programs to IND approval Strategic partnership with Biocodex in biotherapeutics development and manufacturing adds significant non-dilutive funding in addition to the Series B financing Investment fuels expansion of proprietary CORAL® platform and pipeline MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced the successful closing of a €55 million (US$64 million) Series B financing round. The round was led by French pharmaceutical group Biocodex and included strong participation from German-based ATHOS, as well as new investor BNP Paribas Fortis Private Equity and existing investors SFPIM, Ackermans & van Haaren (AvH), OMX Europe Venture Fund (OMX), Qbic II and VIB. Validation of Leadership Position in Microbiome-Based Therapeutics Proceeds will enable MRM Heal

Abbove Unveils “Mia”: Opening a New Chapter in Digital Wealth Planning in Europe4.9.2025 06:00:00 CEST | Press release

Artificial Intelligence at the service of wealth advisors and their clients Abbove, the European platform for collaborative and family-centered wealth planning, announces today the launch of Mia, its new artificial intelligence agent. Used by more than 1,100 advisors and deployed to over 37,000 families across Europe, Abbove takes a major step forward in its mission to reimagine the wealth advisory experience in the digital age. Designed to enhance the capabilities of wealth advisors, family officers, and financial experts, Mia acts as an intelligent co-pilot. It simplifies the reading and analysis of complex estate documents, automatically extracts key information, and assists users in the understanding, enrichment, and structuring of wealth data. “The launch of Mia opens an entirely new functional AI vertical on our platform, unlocking near-infinite possibilities for future development. It’s a key milestone that brings us closer to our ambition of becoming the leading pan-European we

Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions4.9.2025 02:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies and Merck KGaA, Darmstadt, Germany, a leading science and technology company, have entered into an evaluation and option agreement to advance the development of antibody-conjugated lipid-based delivery solutions for nucleic acid payloads, such as antibody-conjugated lipid nanoparticle (LNP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903434045/en/ Under the terms of the agreement, Biocytogen will provide proprietary, fully human antibodies derived from its RenMice® platform for evaluation in Merck KGaA, Darmstadt, Germany’s antibody-conjugated LNP services. Merck KGaA, Darmstadt, Germany has been granted an exclusive option to acquire rights to selected antibody assets in return for fees and royalties on sales and su

OpZira, Inc. Launches to Advance Ophthalmic Diagnostics with Innovative Medical Device Portfolio3.9.2025 19:23:00 CEST | Press release

OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced its official formation. OpZira is dedicated to delivering innovative technologies that enhance the detection and monitoring of ocular disease, empowering clinicians with advanced diagnostic tools. OpZira’s creation follows Alcon’s acquisition of LumiThera (https://www.alcon.com/media-release/alcon-completes-acquisition-lumithera/) and its innovative Valeda® Light Delivery System, the first and only FDA-authorized treatment for dry age-related macular degeneration (AMD). As part of the transaction, LumiThera’s diagnostic product lines were spun off to LumiThera shareholders, leading to the establishment of OpZira, Inc. OpZira’s product portfolio includes: AdaptDx Pro® – A wearable dark adaptometer that leverages AI to ensure a consistent patient experience. Impaired dark adaptation speed, a key early indicator of rod-mediated dysfunction, is often among the fir

​BTG Bioliquids and NanosTech Partner to Deliver End-to-End Advanced Biofuels Solution3.9.2025 18:19:00 CEST | Press release

BTG Bioliquids BV (BTL), a Netherlands-based leader in fast pyrolysis technology, and NanosTech Technology & Innovations Ltd. (NanosTech), a Canada-based catalyst development and manufacturing company, have signed a Memorandum of Understanding (MOU) to deliver a fully integrated solution to produce advanced, drop-in biofuels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903698730/en/ The partnership combines BTL’s proven fast pyrolysis technology, which converts sustainable biomass into bio-oil, with NanosTech’s proprietary Aquaprocessing (AQP) platform, which upgrades even the most challenging bio-oils into refinery-ready feedstocks to produce fuels such as sustainable aviation fuel (SAF), renewable diesel, and marine fuels. The two companies are now actively collaborating to determine the location in Canada and Europe for the new 500-barrel-per-day modular biorefinery system. This system can be deployed near the feeds

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye